Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus.
Black KJ, Nasrallah H, Isaacson S, Stacy M, Pahwa R, Adler CH, Alva G, Cooney JW, Kremens D, Menza MA, Meyer JM, Patkar AA, Simuni T, Morrissette DA, Stahl SM.
Black KJ, et al. Among authors: stacy m.
CNS Spectr. 2019 Oct;24(5):574-575. doi: 10.1017/S1092852919000932.
CNS Spectr. 2019.
PMID: 31182180
No abstract available.